another patent from the far east that will hopefully work for us!
Novel mRNA adjuvant ImmunER enhances ... - Advanced Prostate...
Novel mRNA adjuvant ImmunER enhances prostate cancer tumor-associated antigen mRNA therapy: in vitro and in vivo
Written by
Maxone73
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Addition of an ARSI to standard ADT significantly increases the risk of fractures and falls in men with prostate cancer
Jones C, Gray S, Brown M, et al. Risk of fractures and falls in men with advanced or metastatic...
Examining Prostate Cancer Survival Outcomes by Patient Age and Treatment Type in Patients with mHSPC
“the research suggests a differential impact between androgen receptor antagonists (like...
Pluvicto and prostate cancer in the bone (spine)
I have heard the Pluvicto is not the best solution for cancer in the bone due to red blood cell...
64Cu-SAR-bisPSMA Is Safe and Highly Effective in Detecting Tumours in Prostate Cancer Patients: results from COBRA trial
This could mean being way more precise in finding micro metastasis and in guided surgery!...
Prostate Cancer (stage IV) identified in January and Small Cell Carcinoma (Neuro endocrine) in liver in August. Any suggestions?
In January, my dad was diagnosed with Prostate Cancer (Acinar Adenocarcinoma Prostate) stage 4,...
Related Posts
Revisiting Intermittent Therapy in Metastatic Prostate Cancer
Anti-Androgen Therapy and Bone Tumors in Prostate Cancer
PTEN loss is not a determinant of time to castration-resistance following androgen-deprivation therapy in prostate cancer
The human microbiome and its link in prostate cancer risk and pathogenesis- Title :Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer
